151 related articles for article (PubMed ID: 38423785)
1. Robust Quantification of Phosphodiesterase-4D in Monkey Brain with PET and
Jiang M; Tang S; Jenkins MD; Lee AC; Kenou B; Knoer C; Montero Santamaria J; Wu S; Liow JS; Zoghbi SS; Zanotti-Fregonara P; Innis RB; Telu S; Pike VW
J Nucl Med; 2024 May; 65(5):788-793. PubMed ID: 38423785
[TBL] [Abstract][Full Text] [Related]
2. Discovery, Radiolabeling, and Evaluation of Subtype-Selective Inhibitors for Positron Emission Tomography Imaging of Brain Phosphodiesterase-4D.
Wakabayashi Y; Telu S; Dick RM; Fujita M; Ooms M; Morse CL; Liow JS; Hong JS; Gladding RL; Manly LS; Zoghbi SS; Mo X; D'Amato EC; Sindac JA; Nugent RA; Marron BE; Gurney ME; Innis RB; Pike VW
ACS Chem Neurosci; 2020 May; 11(9):1311-1323. PubMed ID: 32212718
[TBL] [Abstract][Full Text] [Related]
3. An Empirical Quantitative Structure-Activity Relationship Equation Assists the Discovery of High-Affinity Phosphodiesterase 4D Inhibitors as Leads to PET Radioligands.
Jiang M; Lu S; Telu S; Pike VW
J Med Chem; 2023 Jan; 66(2):1543-1561. PubMed ID: 36608175
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of candidate PET radioligands for corticotropin-releasing factor type-1 receptors.
Lodge NJ; Li YW; Chin FT; Dischino DD; Zoghbi SS; Deskus JA; Mattson RJ; Imaizumi M; Pieschl R; Molski TF; Fujita M; Dulac H; Zaczek R; Bronson JJ; Macor JE; Innis RB; Pike VW
Nucl Med Biol; 2014 Jul; 41(6):524-35. PubMed ID: 24793011
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Evaluation of 6 Analogs of
Lee JH; Siméon FG; Liow JS; Morse CL; Gladding RL; Santamaria JAM; Henter ID; Zoghbi SS; Pike VW; Innis RB
J Nucl Med; 2022 Aug; 63(8):1252-1258. PubMed ID: 35027372
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and preliminary studies of
Zhang X; Zhang Y; Chen Z; Shao T; Van R; Kumata K; Deng X; Fu H; Yamasaki T; Rong J; Hu K; Hatori A; Xie L; Yu Q; Ye W; Xu H; Sheffler DJ; Cosford NDP; Shao Y; Tang P; Wang L; Zhang MR; Liang SH
Theranostics; 2020; 10(24):11178-11196. PubMed ID: 33042277
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and initial evaluation of [11C](R)-RWAY in monkey-a new, simply labeled antagonist radioligand for imaging brain 5-HT1A receptors with PET.
McCarron JA; Zoghbi SS; Shetty HU; Vermeulen ES; Wikström HV; Ichise M; Yasuno F; Halldin C; Innis RB; Pike VW
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1670-82. PubMed ID: 17579853
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of translocator 18 kDa protein (TSPO) positron emission tomography (PET) radioligands with low binding sensitivity to human single nucleotide polymorphism rs6971.
Zanotti-Fregonara P; Zhang Y; Jenko KJ; Gladding RL; Zoghbi SS; Fujita M; Sbardella G; Castellano S; Taliani S; Martini C; Innis RB; Da Settimo F; Pike VW
ACS Chem Neurosci; 2014 Oct; 5(10):963-71. PubMed ID: 25123416
[TBL] [Abstract][Full Text] [Related]
9. First-in-Human Evaluation of
Wakabayashi Y; Stenkrona P; Arakawa R; Yan X; Van Buskirk MG; Jenkins MD; Santamaria JAM; Maresca KP; Takano A; Liow JS; Chappie TA; Varrone A; Nag S; Zhang L; Hughes ZA; Schmidt CJ; Doran SD; Mannes A; Zanotti-Fregonara P; Ooms M; Morse CL; Zoghbi SS; Halldin C; Pike VW; Innis RB
J Nucl Med; 2022 Dec; 63(12):1919-1924. PubMed ID: 35772961
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo.
Briard E; Zoghbi SS; Imaizumi M; Gourley JP; Shetty HU; Hong J; Cropley V; Fujita M; Innis RB; Pike VW
J Med Chem; 2008 Jan; 51(1):17-30. PubMed ID: 18067245
[TBL] [Abstract][Full Text] [Related]
11. Characterization of [
Yang KC; Stepanov V; Amini N; Martinsson S; Takano A; Nielsen J; Bundgaard C; Bang-Andersen B; Grimwood S; Halldin C; Farde L; Finnema SJ
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):308-320. PubMed ID: 27817159
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization in monkey of [11C]SP203 as a radioligand for imaging brain metabotropic glutamate 5 receptors.
Siméon FG; Liow JS; Zhang Y; Hong J; Gladding RL; Zoghbi SS; Innis RB; Pike VW
Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1949-58. PubMed ID: 22885775
[TBL] [Abstract][Full Text] [Related]
13. Development of LC-MS/MS-based receptor occupancy tracers and positron emission tomography radioligands for the nociceptin/orphanin FQ (NOP) receptor.
Pedregal C; Joshi EM; Toledo MA; Lafuente C; Diaz N; Martinez-Grau MA; Jiménez A; Benito A; Navarro A; Chen Z; Mudra DR; Kahl SD; Rash KS; Statnick MA; Barth VN
J Med Chem; 2012 Jun; 55(11):4955-67. PubMed ID: 22541041
[TBL] [Abstract][Full Text] [Related]
14. 3-Substituted 1,5-Diaryl-1 H-1,2,4-triazoles as Prospective PET Radioligands for Imaging Brain COX-1 in Monkey. Part 2: Selection and Evaluation of [
Shrestha S; Singh P; Cortes-Salva MY; Jenko KJ; Ikawa M; Kim MJ; Kobayashi M; Morse CL; Gladding RL; Liow JS; Zoghbi SS; Fujita M; Innis RB; Pike VW
ACS Chem Neurosci; 2018 Nov; 9(11):2620-2627. PubMed ID: 29792035
[TBL] [Abstract][Full Text] [Related]
15. Further evaluation of [11C]MP-10 as a radiotracer for phosphodiesterase 10A: PET imaging study in rhesus monkeys and brain tissue metabolite analysis.
Lin SF; Labaree D; Chen MK; Holden D; Gallezot JD; Kapinos M; Teng JK; Najafzadeh S; Plisson C; Rabiner EA; Gunn RN; Carson RE; Huang Y
Synapse; 2015 Feb; 69(2):86-95. PubMed ID: 25450608
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of [11C]PipISB and [18F]PipISB in monkey as candidate radioligands for imaging brain cannabinoid type-1 receptors in vivo.
Finnema SJ; Donohue SR; Zoghbi SS; Brown AK; Gulyás B; Innis RB; Halldin C; Pike VW
Synapse; 2009 Jan; 63(1):22-30. PubMed ID: 18925657
[TBL] [Abstract][Full Text] [Related]
17. Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.
Bao X; Lu S; Liow JS; Zoghbi SS; Jenko KJ; Clark DT; Gladding RL; Innis RB; Pike VW
J Med Chem; 2012 Mar; 55(5):2406-15. PubMed ID: 22313227
[TBL] [Abstract][Full Text] [Related]
18. Development of a series of novel carbon-11 labeled PDE10A inhibitors.
Stepanov V; Miura S; Takano A; Amini N; Nakao R; Hasui T; Nakashima K; Taniguchi T; Kimura H; Kuroita T; Halldin C
J Labelled Comp Radiopharm; 2015 May; 58(5):202-8. PubMed ID: 25891816
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of two new candidate high-affinity full agonist PET radioligands for imaging 5-HT
Lindberg A; Lu S; Nag S; Schou M; Liow JS; Zoghbi SS; Frankland MP; Gladding RL; Morse CL; Takano A; Amini N; Elmore CS; Lee YS; Innis RB; Halldin C; Pike VW
Nucl Med Biol; 2019 Mar; 70():1-13. PubMed ID: 30811975
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, 18F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron Emission Tomography.
Schröder S; Wenzel B; Deuther-Conrad W; Teodoro R; Egerland U; Kranz M; Scheunemann M; Höfgen N; Steinbach J; Brust P
Molecules; 2015 May; 20(6):9591-615. PubMed ID: 26016549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
